Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma

  title={Impact of Surgical Resection of the Primary Tumor on Overall Survival in Patients With Metastatic Pheochromocytoma or Sympathetic Paraganglioma},
  author={A. Rom{\'a}n-Gonz{\'a}lez and S. Zhou and M. Ayala-Ramirez and C. Shen and S. Waguespack and M. Habra and J. Karam and N. Perrier and C. Wood and C. Jim{\'e}nez},
  journal={Annals of Surgery},
  • A. Román-González, S. Zhou, +7 authors C. Jiménez
  • Published 2018
  • Medicine
  • Annals of Surgery
  • Objective: To determine whether primary tumor resection in patients with metastatic pheochromocytoma or paraganglioma (PPG) is associated with longer overall survival (OS). Background: Patients with metastatic PPG have poor survival outcomes. The impact of surgical resection of the primary tumor on OS is not known. Methods: We retrospectively studied patients with metastatic PPG treated at the University of Texas, MD Anderson Cancer Center from January 2000 through January 2015. Kaplan-Meier… CONTINUE READING
    26 Citations
    Management and outcome of metastatic pheochromocytomas/paragangliomas: an overview
    Pheochromocytoma and Paraganglioma: From Treatment to Follow-up
    Paraganglioma of the Urinary Bladder: A Series of 22 Cases in a Single Center
    • 14
    Metastatic pheochromocytoma and paraganglioma: recent advances in prognosis and management
    • Oksana Hamidi
    • Medicine
    • Current opinion in endocrinology, diabetes, and obesity
    • 2019
    • 9
    Treatment for Patients With Malignant Pheochromocytomas and Paragangliomas: A Perspective From the Hallmarks of Cancer
    • 23
    • Highly Influenced
    • PDF


    Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma.
    • 59
    Current and Future Treatments for Malignant Pheochromocytoma and Sympathetic Paraganglioma
    • 110
    Therapy of endocrine disease: treatment of malignant pheochromocytoma and paraganglioma.
    • 81
    • PDF
    Constipation: an overlooked, unmanaged symptom of patients with pheochromocytoma and sympathetic paraganglioma.
    • 23
    • PDF
    Mortality associated with phaeochromocytoma.
    • 31
    Malignant pheochromocytoma and paraganglioma: future considerations for therapy.
    • R. Buzzoni, S. Pusceddu, +9 authors M. Castellani
    • Medicine
    • The quarterly journal of nuclear medicine and molecular imaging : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology (IAR), [and] Section of the Society of...
    • 2013
    • 8